Form 4: Schwab Executive Jonathan Beatty Reports Stock Option Exercise and Share Sale
SEC Form 4 Filing
Jonathan Beatty, MD, Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged trading plan.
Summary
- On July 11, 2024, Jonathan Beatty exercised nonqualified stock options to acquire 780 shares of Charles Schwab Corp common stock at a price of $44.24 per share.
- The acquired shares were then contributed to a trust.
- Simultaneously, Beatty sold 780 shares of common stock at a weighted average price of $75.0026 per share, with individual trades ranging from $75.00 to $75.02.
- The sale was executed under a Rule 10b5-1 trading plan adopted on February 28, 2024.
- Following these transactions, Beatty directly owns 11,158 derivative securities and 36,981 shares and indirectly owns 18,069 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. There's no indication of positive or negative sentiment towards the company's prospects.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, suggesting they were planned well in advance and not based on any inside information.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like Jonathan Beatty, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a common tool used by executives to sell shares in a pre-planned manner, avoiding accusations of insider trading.
- The reported transactions are typical for executives at publicly traded companies like Charles Schwab.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they represent a small portion of the company's outstanding shares.
Key Dates
| Date | Description |
|---|---|
| February 28, 2024 | Date of adoption of Rule 10b5-1 trading plan. |
| July 11, 2024 | Date of stock option exercise and share sale. |
| July 15, 2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.